A three year postdoctoral position is available in my group, investigating plant centromere structure, function and evolution @plantscijobs.cam.ac.uk/job/51488/
Update on ##Recombination25 Conference! 🚨
📅RD & PS Deadline: 13th March 2025. DON'T MISS OUT!
🌟Grants are available for students, postdocs & junior investigators!🌟
For more details, visit bit.ly/41v8IuK or email Felicity at 📧felicity@fusion-conferences.com
Hello friends! Just a reminder that we have made the move to the blue place 🦋 and I will delete this account at the end of the month. Please migrate with us!
Free scientific illustrations for biologists! 😍
@NIH has released a library of 500 free scientific illustrations to create figures, presentations, and illustrations!
all freely available in the public domain.
Retweet and spread the message!
bioart.niaid.nih.gov/
Collaborative paper alerts! The 1st on PDL1 role in DDR is being proofed rn so I'll post next week. 2nd is this beauty from the @PatrickSungLab "Distinct roles of the two BRCA2 DNA binding domains in DNA damage repair and replication fork preservation" biorxiv.org/content/10.1101/…
Hey science peeps! I get a ton of requests to edit manuscripts. Accepted one, obviously written by AI. Ran it, came back 100% AI,0% human, 5 different detectors. Today, nasty email from editor in chief telling me they don't accept my rejection, and to send it 4 review 1/3
First of all, the nerves! I am not on payroll, reviewers are not on payroll. Why are we to waste time we don't have on a machine written manuscript? As far as I am aware, AI is not accepted by main publishers (yes, small title from one of the big publishing groups).
2nd, AI is getting better everyday. We should be clear that articles need to be written by people and based on real data now, as soon enough there won't be a call to be made. There are way too many new paper submissions for all of them to be real. Anyone else feels like me? 3/3
Last day of Entrepreneurs Bootcamp at @Geekdom San Antonio. So much info, so much networking, and such great mentorship! I loved meeting this cohort and we will see each other again. Now, who want to hear my elevator pitch?! 😁
Hello, DNA repair Tweeter peeps! We have a fab cryo-EM facility but they cannot take just any project I throw at them (time constraints scientific choices). Who is your go to cryo-EM facility? Please contact me directly if you're a structural core with some time or interest!
New paper alert! Aurkin-A, a TPX2-aurora a small molecule inhibitor disrupts Alisertib-induced polyploidy in aggressive diffuse large B cell lymphoma published today 1/3 authors.elsevier.com/sd/arti…
Not going to lie, this one took some serious effort! Very enjoyable collaboration with the Mahadevan lab @UTHealthSAMDA @UTHSAResearch where we find that Alisertib, an ATP site inhibitor of Aurora A kinase, induces cell cycle dysregulation and polyploidy in DLBL 2/3
Polyploidy is bad as it promotes drug resistance is linked w/ poor outcomes. Thankfully, the combination of alisertib and Aurkin A, an Aurora A TPX2 site inhibitor, ↘️ polyploidy and ↗️ apoptosis. Basic science at the service of drug development, stay tuned for translation! 3/3
I was a little slow posting this, but congrats to PJ *doctor* Conway on graduating! Joint mentoring with Dr Mahadevan was a breeze. Keep an eye out for PJ's beautiful paper on cell cycle analysis and polyploidy in Lymphoma, which I hope will be accepted and shared here soon!
What a great way to start the day. This superb work from the Pillai lab, driven by Prajwal Boddu and a little help from us @bdelapenavalos is finally in print @MolecularCell Highlight: SF3B1 oncogenic mutations reduce RNAPII gene-body elongation rate. sciencedirect.com/science/ar…
Amazing new work from the Pickett lab @hildaApickett and collaborators! This story on #EYA#phosphatase is gorgeous, complex, well done Hilda and everyone in the lab for getting it published! Can't wait to collaborate again and share the follow up stories nature.com/articles/s41467-0…